Just wanted to write and say that I'm VERY satisfied with my purchase. I was
skeptical at first, the price seemed too good and the shipping process too
convoluted. But I sucked it up and took the plunge, ordered 90 of the lil blue guys
and sat back to wait for packages that might never come. Happily I was SO wrong! 9
days after my order was placed I received my first batch of 30+4, and just today
(another week later) I received the remaining 60. The quality of the product is
outstanding. If you\'re sitting there, wondering whether or not you should go ahead
and make a purchase here, quit wondering! The best prices, excellent service, and a
top-notch product are all present here. Go for it!
HCV Patients May Be Able to Delay Therapy - MedPage Today
HCV Patients May Be Able to Delay TherapyMedPage TodayThe addition of new protease inhibitors telaprevir (Incivek) and boceprevir (Victrelis) to previous standard therapy of interferon and ribavirin have significantly boosted sustained viral response for many patients, especially for blacks and Latinos, .
Medivir: Interim Report, 1 January -- 31 March 2012 - MarketWatch (press release)
Medivir: Interim Report, 1 January -- 31 March 2012MarketWatch (press release)Apart from interferon and ribavirin-free combination trials on TMC435 in phase II, this collaboration now also covers a phase III program Medivir opened 2012 with continued stable sales of Rx pharmaceuticals.
Hepatitis C lurks inside baby boomers - Meriden Record-Journal
CBS LocalHepatitis C lurks inside baby boomersMeriden Record-JournalThe protease inhibitors are typically used with pegylated interferon and ribavirin and increase the cure rate up to 75 percent, according to the CDC.
Twelve Weeks of GS-7977 Eliminates HCV as Well as 24 Weeks - Medscape
Twelve Weeks of GS-7977 Eliminates HCV as Well as 24 WeeksMedscapeMay 2, 2012 (Barcelona, Spain) — Twelve weeks of GS-7977 (Gilead Sciences) plus pegylated interferon (pegIFN) and ribavirin was as effective as 24 weeks of treatment in eliminating hepatitis C virus (HCV) genotype 1.
Experts Discuss DAAs for Difficult-To-Treat Hep C Patients - Infectious Disease Special Edition
Infectious Disease Special EditionExperts Discuss DAAs for Difficult-To-Treat Hep C PatientsInfectious Disease Special EditionOverall, the new reports revealed the following: Cirrhotic patients who previously received the standard two-drug therapy and then received telaprevir in combination with pegylated interferon (Peg-IFN) and ribavirin had improved SVR compared with .